Home Cart Sign in  
Chemical Structure| 915296-00-3 Chemical Structure| 915296-00-3

Structure of Elotuzumab
CAS No.: 915296-00-3

Chemical Structure| 915296-00-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Elotuzumab is a humanized IgG1 monoclonal antibody that targets multiple myeloma cells by binding to SLAMF7. Elotuzumab has potential for multiple myeloma research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Elotuzumab

CAS No. :915296-00-3
M.W : 145.44 kDa
SMILES Code : NONE

Safety of Elotuzumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02541643 Multiple Myeloma NO_LONGER_AVAILABLE - Icahn School.of Medicine at Mo... More >>unt Sinai, New York, New York, 10029, United States Less <<
NCT03393273 Multiple Myeloma PHASE2 WITHDRAWN 2019-01-15 Hématologie et thérapie cellul... More >>aire, H?pital Saint Antoine, Paris, 75012, France Less <<
NCT03361306 Multiple Myeloma PHASE2 ACTIVE_NOT_RECRUITING 2025-02-25 Levine Cancer Institute, Charl... More >>otte, North Carolina, 28204, United States Less <<
 

Historical Records

Categories